In this video, Dr Bruce Sands discusses the current role of JAK inhibitors for the treatment of IBD and whether or not gastroenterologists should be concerned with adverse events.
Dr James Matera from CentraState Medical Center in Freehold, NJ, gives us an overview of his session from the 2018 Cardiometabolic Risk Summit in San Antonio, TX.